Estadístiques de Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: a one-year extension study
Visites totals
| views | |
|---|---|
| Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: a one-year extension study | 57 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 1 |
| September 2024 | 2 |
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| maurer-all-sust.pdf(legacy) | 40 |
| maurer-all-sust.pdf | 6 |
Vistes principals per país
| views | |
|---|---|
| United States | 48 |
| Netherlands | 2 |
| Sweden | 2 |
| Czechia | 1 |
| Germany | 1 |
| Spain | 1 |
| Israel | 1 |
| Iran | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 14 |
| Boardman | 10 |
| Ann Arbor | 7 |
| Ashburn | 3 |
| Mountain View | 3 |
| San Diego | 2 |
| Cambridge | 1 |
| Casper | 1 |
| Córdoba | 1 |
| Portland | 1 |
| Rochester | 1 |
| Seattle | 1 |